Overview

Low Intracranial Pressure Treatment Strategies for Chronic Subdural Hematoma Patients

Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
The proportion of the elderly population is increasing rapidly. Chronic subdural hematoma has become the most common cause of surgery in neurosurgery for elderly patients. The standard treatment for cSDH is mostly surgery. Clinically, we often encounter elderly patients with certain underlying diseases or organ dysfunction, especially preexisting cardiovascular disease or medication history like anticoagulant or antiplatelet drugs, resulting in poor surgical tolerance, high risk during anesthesia and hematoma recurrence. At present, the mechanism of cSDH is not completely clear. Our previous observational studies had shown significant correlation between cSDH and intracranial hypotension. So we would like to conduct a randomized, controlled, multi-center clinical study to explore the effectiveness and safety of low intracranial pressure treatment strategies for patients with chronic subdural hematoma.
Phase:
N/A
Details
Lead Sponsor:
Huashan Hospital
Treatments:
Atorvastatin
Dexamethasone